Burcon Launches Groundbreaking Sunflower Protein Isolate
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has launched Solatein™, a groundbreaking high-purity sunflower protein isolate. The product features over 90% protein purity and is designed to meet growing consumer demand for protein supplements, particularly among GLP-1 weight management medication users.
Solatein™ offers unique characteristics including neutral flavor, off-white color, and exceptional functionality for food and beverage applications. The non-GMO, hypoallergenic protein is rich in sulfur-containing amino acids and is produced through an innovative process that upcycles sunflower seed oil production by-products.
According to Goldman Sachs Research, GLP-1 medication users are expected to increase significantly over the next five years, creating new opportunities in the protein supplement market. Burcon's expanded portfolio aims to address this growing demand with its highly differentiated plant-based protein solutions.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha lanciato Solatein™, un innovativo isolato proteico di alta purezza da semi di girasole. Il prodotto offre oltre 90% di purezza proteica ed è progettato per soddisfare la crescente domanda dei consumatori per integratori proteici, in particolare tra gli utenti di farmaci per la gestione del peso GLP-1.
Solatein™ presenta caratteristiche uniche, tra cui un sapore neutro, un colore bianco-off e un'eccezionale funzionalità per applicazioni alimentari e bevande. Questa proteina non OGM e ipoallergenica è ricca di aminoacidi contenenti zolfo ed è prodotta attraverso un processo innovativo che riutilizza i sottoprodotti della produzione dell'olio di semi di girasole.
Secondo Goldman Sachs Research, si prevede che il numero di utenti di farmaci GLP-1 aumenterà significativamente nei prossimi cinque anni, creando nuove opportunità nel mercato degli integratori proteici. Il portafoglio ampliato di Burcon mira a rispondere a questa crescente domanda con le sue soluzioni proteiche vegetali altamente differenziate.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) ha lanzado Solatein™, un innovador aislado de proteína de girasol de alta pureza. El producto presenta más de 90% de pureza proteica y está diseñado para satisfacer la creciente demanda de suplementos de proteína, especialmente entre los usuarios de medicamentos para el control de peso GLP-1.
Solatein™ ofrece características únicas, incluyendo un sabor neutro, un color blanco cremoso y una funcionalidad excepcional para aplicaciones alimentarias y de bebidas. La proteína es no OGM, hipoalergénica y rica en aminoácidos que contienen azufre, y se produce a través de un proceso innovador que recicla subproductos de la producción de aceite de semilla de girasol.
Según Goldman Sachs Research, se espera que el número de usuarios de medicamentos GLP-1 aumente significativamente en los próximos cinco años, creando nuevas oportunidades en el mercado de suplementos de proteína. El portafolio ampliado de Burcon busca abordar esta creciente demanda con sus soluciones de proteína de origen vegetal altamente diferenciadas.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF)가 고순도 해바라기 단백질 분리물인 Solatein™을 출시했습니다. 이 제품은 90% 이상의 단백질 순도를 자랑하며, 특히 GLP-1 체중 관리 약물 사용자들 사이에서 단백질 보충제에 대한 수요 증가에 맞추어 설계되었습니다.
Solatein™은 중립적인 맛, 크림색을 띠는 색상, 식음료 응용에 훌륭한 기능성을 포함한 독특한 특징을 제공합니다. 이 비GMO, 저자극성 단백질은 황을 포함한 아미노산이 풍부하며, 해바라기씨유 생산의 부산물을 재활용하는 혁신적인 과정을 통해 생산됩니다.
골드만삭스 리서치에 따르면, GLP-1 약물 사용자가 향후 5년 이내에 크게 증가할 것으로 예상되며, 이는 단백질 보충제 시장에서 새로운 기회를 창출할 것입니다. Burcon의 확장된 포트폴리오는 이러한 증가하는 수요에 응답하기 위해 고도로 차별화된 식물 기반 단백질 솔루션을 제공합니다.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) a lancé Solatein™, un isolat de protéine de tournesol à haute pureté révolutionnaire. Le produit affiche plus de 90 % de pureté protéique et est conçu pour répondre à la demande croissante des consommateurs pour des compléments protéiques, notamment parmi les utilisateurs de médicaments GLP-1 pour la gestion du poids.
Solatein™ présente des caractéristiques uniques, notamment une saveur neutre, une couleur blanche cassée et une fonctionnalité exceptionnelle pour les applications alimentaires et de boissons. Cette protéine non-OGM et hypoallergénique est riche en acides aminés contenant du soufre et est produite par un processus innovant qui valorise les sous-produits de la production d'huile de graines de tournesol.
Selon Goldman Sachs Research, le nombre d'utilisateurs de médicaments GLP-1 devrait augmenter considérablement au cours des cinq prochaines années, créant ainsi de nouvelles opportunités sur le marché des compléments protéiques. Le portefeuille élargi de Burcon vise à répondre à cette demande croissante avec ses solutions de protéines végétales hautement différenciées.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) hat Solatein™, ein bahnbrechendes isoliertes Sonnenblumenprotein mit hoher Reinheit, auf den Markt gebracht. Das Produkt weist über 90 % Proteinreinheit auf und wurde entwickelt, um die wachsende Nachfrage der Verbraucher nach Proteinpräparaten zu decken, insbesondere bei Nutzern von GLP-1-Medikamenten zur Gewichtsreduktion.
Solatein™ bietet einzigartige Eigenschaften, darunter einen neutralen Geschmack, eine cremeweiße Farbe und außergewöhnliche Funktionalität für Lebensmittel- und Getränkeanwendungen. Das nicht-GVO- und hypoallergene Protein ist reich an schwefelhaltigen Aminosäuren und wird durch einen innovativen Prozess hergestellt, der Nebenprodukte der Sonnenblumenölproduktion wiederverwertet.
Laut Goldman Sachs Research wird die Zahl der Nutzer von GLP-1-Medikamenten in den nächsten fünf Jahren voraussichtlich erheblich steigen, was neue Möglichkeiten auf dem Markt für Proteinpräparate schafft. Das erweiterte Portfolio von Burcon zielt darauf ab, diese wachsende Nachfrage mit seinen hochdifferenzierten pflanzlichen Proteinlösungen zu bedienen.
- Launch of innovative high-purity (90%+) sunflower protein isolate
- Product targets growing GLP-1 medication users market
- Sustainable production process utilizing sunflower oil by-products
- Product features superior functionality and neutral taste profile
- None.
Next generation of high-quality, sustainable plant-based protein now available for sampling
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, is proud to announce the launch of Solatein™ sunflower protein isolate, a groundbreaking high-purity protein ingredient designed to meet the evolving preferences of consumers worldwide.
An emerging sector of consumers prioritizing protein intake is creating new opportunities for protein supplement products. According to Goldman Sachs Research, the number of GLP-1 weight management medication users is expected to increase rapidly over the next five years1. These users are actively seeking protein to support their nutrition needs2. Burcon anticipates that its expanded portfolio of highly differentiated plant-based protein solutions is well-positioned to meet this significant demand.
"We are incredibly proud to launch the world's first high-purity sunflower protein isolate ahead of schedule," said Kip Underwood, Burcon's chief executive officer. "Solatein™ offers one of the best combinations of clean taste, texture and functionality, enhancing a wide range of food and beverage products, including those tailored for GLP-1 users."
Burcon's Solatein™ sunflower protein is expected to redefine the standards for high-purity protein ingredients. It boasts a neutral flavor, off-white color and exceptional functionality, providing ease of formulation in a variety of food applications, in particular, those with delicate flavors. With over
Prospective customers seeking product samples and information are encouraged to contact Benoit Keppenne at bkeppenne@burcon.ca.
About Burcon NutraScience Corporation
Burcon is a global technology leader in the development of plant-based proteins for foods and beverages. Our proteins exhibit superior functionality, taste and nutrition, making them ideal ingredients for food formulators. With over two decades of experience, Burcon has amassed an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. Burcon is committed to delivering next-generation, best-in-class protein solutions, positioning itself as a key player in the rapidly expanding plant-based market. Supporting the growing trend towards a plant-based diet, Burcon offers sustainable protein ingredients that we believe are better for you and better for the planet. For more information, visit www.burcon.ca.
Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations; and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2024 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.
Industry and Investor Contact
Paul Lam
Director, Investor Relations and Communications
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
plam@burcon.ca www.burcon.ca
Media Contact:
Steve Campbell, APR
President
Campbell & Company Public Relations
Tel (604) 888-5267
TECH@CCOM-PR.COM
1Source: Weighing the GLP-1 Market (April 2024) - The Goldman Sachs Group, Inc.
2Source: Wellness in the Era of GLP-1 Medications (September 2024) - Nielsen Consumer LLC
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/236408
FAQ
What is Burcon's (BRCNF) new Solatein™ protein product?
How does Burcon (BRCNF) produce its Solatein™ sunflower protein?
What market opportunity is Burcon (BRCNF) targeting with Solatein™?
What are the key features of Burcon's (BRCNF) Solatein™ protein?
